SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-07-000648
Filing Date
2007-08-08
Accepted
2007-08-08 16:05:39
Documents
8
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a32741e10vq.htm 10-Q 622792
2 EXHIBIT 10.314 a32741exv10w314.htm EX-10.314 20135
3 EXHIBIT 10.316 a32741exv10w316.htm EX-10.316 9735
4 EXHIBIT 10.317 a32741exv10w317.htm EX-10.317 36198
5 EXHIBIT 31.1 a32741exv31w1.htm EX-31.1 6225
6 EXHIBIT 31.2 a32741exv31w2.htm EX-31.2 6223
7 EXHIBIT 32.1 a32741exv32w1.htm EX-32.1 3305
8 EXHIBIT 32.2 a32741exv32w2.htm EX-32.2 3298
  Complete submission text file 0000936392-07-000648.txt   709323
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 071035740
SIC: 2834 Pharmaceutical Preparations